|
|
|
|
|
by jellyksong
1967 days ago
|
|
Two questions: 1. I wonder how many times the test set can be used on "incremental changes in future versions of the model" before losing statistical validity. 2. This article describes their process, but not the FDA's process. Are there specific regulatory requirements for ML models beyond their four types of reports? |
|
2) The FDA's guidance on ML models is still in flux. Please see https://www.fda.gov/medical-devices/software-medical-device-...